Categories AlphaGraphs, Earnings, Health Care

Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues

Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also exceeded Wall Street’s projection.

AbbVie Q3 2021 earnings infographic

At $3.33 per share, September-quarter adjusted earnings were higher than $2.83 per share reported in the prior-year quarter and slightly above the consensus estimates. Net income, including special items, was $3.18 billion or $1.78 per share, compared to $2.31 billion or $1.29 per share in the third quarter of 2020.

Driving the bottom-line growth, net revenues increased 11% year-over-year to $14.34 billion. Market watchers were looking for slightly slower growth.


Read management/analysts’ comments on AbbVie’s Q3 results


AbbVie’s shares made modest gains on Friday morning following the earnings announcement, after closing the previous session higher.

Prior Performance

  • Abbvie Q3 2020 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

DG Earnings Preview: What to look for when Dollar General reports Q3 results

Discount store chain Dollar General Corporation (NYSE: DG) will be reporting third-quarter results next week. Operating nearly 20,000 stores across the US, it is one of the largest supermarket chains

Dollar Tree (DLTR): A few points to note about the discount retailer’s Q3 performance

Shares of Dollar Tree, Inc. (NASDAQ: DLTR) were up over 1% on Thursday. The stock has dropped 13% year-to-date. The discount retailer delivered third-quarter 2023 earnings results that did not

KR Earnings: Key quarterly highlights from Kroger’s Q3 2023 financial results

The Kroger Co. (NYSE: KR) reported its third quarter 2023 earnings results today. Total company sales were $34 billion compared to $34.2 billion for the same period last year. Identical sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top